Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study

Author: Paul Bălănescu, Anca Lădaru, Eugenia Bălănescu, Theodor Voiosu, Cristian Băicuş and Gheorghe Andrei Dan
Date Published: September-2015
Source: Journal of Clinical Laboratory Analysis

Systemic sclerosis (Ssc) is an autoimmune disease characterized by vascular alterations of small arteries and microvessels with subsequent tissue fibrosis. Endocan is expressed by endothelial cells and associated with endothelial dysfunction; therefore it could be a potential biomarker for Ssc patients.